Skip to main navigation

Live - Top Menu

  • Clinical Trials
  • Investors & Media
  • Careers
  • Contact Us
Menu
Close

Main navigation

  • Our Focus
  • Our Research
  • Our Medicine
  • Our Story
Home > Investors & Media
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Investors & Media

Data Provided by Refinitiv. Minimum 15 minutes delayed.

:
on
  • Intra
  • 3 mo.
  • 6 mo.
  • 1 yr.

Investors & Media

:
on

Data Provided by Refinitiv. Minimum 15 minutes delayed.

  • Intra
  • 3 mo.
  • 6 mo.
  • 1 yr.
News Releases
FDA Accepts Intercept’s New Drug Application for OCA for the Treatment of Pre-Cirrhotic Liver Fibrosis Due to NASH
Jan 19, 2023
Intercept Pharmaceuticals to Present at J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023
Jan 05, 2023
Intercept Announces Efficacy and Safety Data from Phase 3 REGENERATE Study in Liver Fibrosis due to NASH to be Presented at NASH-TAG Conference 2023
Jan 04, 2023
Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH
Dec 23, 2022
View all press releases >
Recent Events and Presentations
J.P. Morgan 41st Annual Healthcare Conference
Jan 12, 2023 at 12:00 PM PST
Download Audio
Piper Sandler’s 34th Annual Healthcare Conference
Dec 1, 2022
Q3 2022 Intercept Pharmaceuticals Earnings Call
Nov 1, 2022 at 8:30 AM EDT
H.C. Wainwright’s 6th Annual NASH Investor Conference
Oct 17, 2022 at 2:30 PM EDT
View all events & presentations >
  • Investors & Media
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Leadership
      • Board of Directors
    • Financial Information
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Dividend History
      • Analyst Coverage
    • Contact Us

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter

Live - Footer Menu

  • Privacy Policy
  • Privacy Shield Policy
  • Corporate Compliance
  • Terms of Use
  • Contact Us
  • Cookie Preferences
305 Madison Avenue|Morristown, NJ 07960|T: 844-782-ICPT
© 2023 Intercept Pharmaceuticals, Inc.